Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
medicine
Imatinib mesilate for the treatment of gastrointestinal stromal tumour
Expert Opinion on Pharmacotherapy, Volume 9, No. 7, Year 2008
Notification
URL copied to clipboard!
Description
Background: The molecular hallmark of gastrointestinal stromal tumours (GISTs), the mutation of the KIT gene, was discovered 10 years ago. GISTs have since been recognized as separate pathological entities among sarcomas, and have become a model for targeted treatment of solid tumours. Imatinib mesilate, which was approved in 2002 for the treatment of patients with advanced GIST, has dramatically changed the course of the disease. Objective: This article will focus on the development of imatinib mesilate in the treatment of patients with GIST. Methods: A Pubmed search was performed using the keywords 'imatinib', 'gastrointestinal stromal', 'GIST', 'KIT' and 'PDGFR'. Websites of the American Society of Clinical Oncolooy and the European Society of Medical Oncology were searched for data reported in abstract form at recent symposiums. Personal communications from opinion leaders were sought for additional information that might be relevant. Results: Imatinib has changed the clinical course of patients with advanced GISTs and further development in the adjuvant setting as well as prospective assessment of predictive factors are the current focus of ongoing research. © 2008 Informa UK Ltd.
Authors & Co-Authors
Cassier, Philippe Alexandre
Unknown Affiliation
Arifi, Samia
Unknown Affiliation
Ray-Coquard, Isabelle Laure
France, Lyon
Le Centre Régional de Lutte Contre le Cancer Léon Bérard
Sunyach, Marie Pierre
France, Lyon
Le Centre Régional de Lutte Contre le Cancer Léon Bérard
Blay, Jean Yves
France, Paris
Inserm
Statistics
Citations: 21
Authors: 5
Affiliations: 2
Identifiers
Doi:
10.1517/14656566.9.7.1211
ISSN:
14656566
Research Areas
Cancer
Genetics And Genomics
Study Design
Cohort Study